158 related articles for article (PubMed ID: 15556150)
1. Exhaled Interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys).
Carpagnano GE; Resta O; Foschino-Barbaro MP; Spanevello A; Stefano A; Di Gioia G; Serviddio G; Gramiccioni E
Eur J Pharmacol; 2004 Nov; 505(1-3):169-75. PubMed ID: 15556150
[TBL] [Abstract][Full Text] [Related]
2. Prevention of acute exacerbations of chronic obstructive bronchitis with carbocysteine lysine salt monohydrate: a multicenter, double-blind, placebo-controlled trial.
Allegra L; Cordaro CI; Grassi C
Respiration; 1996; 63(3):174-80. PubMed ID: 8739489
[TBL] [Abstract][Full Text] [Related]
3. Increased alveolar nitric oxide concentration and high levels of leukotriene B(4) and 8-isoprostane in exhaled breath condensate in patients with asbestosis.
Lehtonen H; Oksa P; Lehtimäki L; Sepponen A; Nieminen R; Kankaanranta H; Saarelainen S; Järvenpää R; Uitti J; Moilanen E
Thorax; 2007 Jul; 62(7):602-7. PubMed ID: 17251310
[TBL] [Abstract][Full Text] [Related]
4. Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease.
Foschino Barbaro MP; Carpagnano GE; Spanevello A; Cagnazzo MG; Barnes PJ
Int J Immunopathol Pharmacol; 2007; 20(4):753-63. PubMed ID: 18179748
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 8-isoprostane and interleukin-8 in induced sputum and exhaled breath condensate from asymptomatic and symptomatic smokers.
Mazur W; Stark H; Sovijärvi A; Myllärniemi M; Kinnula VL
Respiration; 2009; 78(2):209-16. PubMed ID: 19252398
[TBL] [Abstract][Full Text] [Related]
6. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD.
Biernacki WA; Kharitonov SA; Barnes PJ
Thorax; 2003 Apr; 58(4):294-8. PubMed ID: 12668789
[TBL] [Abstract][Full Text] [Related]
7. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers.
Montuschi P; Collins JV; Ciabattoni G; Lazzeri N; Corradi M; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):1175-7. PubMed ID: 10988150
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress levels in exhaled breath condensate associated with COPD and smoking.
Inonu H; Doruk S; Sahin S; Erkorkmaz U; Celik D; Celikel S; Seyfikli Z
Respir Care; 2012 Mar; 57(3):413-9. PubMed ID: 21968597
[TBL] [Abstract][Full Text] [Related]
9. Effect of CArbocisteine in Prevention of exaceRbation of chronic obstructive pulmonary disease (CAPRI study): An observational study.
Esposito A; Valentino MR; Bruzzese D; Bocchino M; Ponticiello A; Stanziola A; Sanduzzi A
Pulm Pharmacol Ther; 2016 Apr; 37():85-8. PubMed ID: 26970503
[TBL] [Abstract][Full Text] [Related]
10. Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation.
Carpagnano GE; Kharitonov SA; Foschino-Barbaro MP; Resta O; Gramiccioni E; Barnes PJ
Thorax; 2004 Dec; 59(12):1016-9. PubMed ID: 15563698
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of the effects of carbocysteine lysine salt on frequency of exacerbations in COPD patients treated with or without inhaled steroids.
Paone G; Lanata L; Saibene F; Toti S; Palermo P; Graziani C; Flore MC; Ramaccia M; Puglisi G
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6727-6735. PubMed ID: 31378916
[TBL] [Abstract][Full Text] [Related]
12. Relationship between exhaled leukotriene and 8-isoprostane levels and asthma severity, asthma control level, and asthma control test score.
Keskin O; Balaban S; Keskin M; Kucukosmanoglu E; Gogebakan B; Ozkars MY; Kul S; Bayram H; Coskun Y
Allergol Immunopathol (Madr); 2014; 42(3):191-7. PubMed ID: 23265270
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress in expired breath condensate of patients with COPD.
Kostikas K; Papatheodorou G; Psathakis K; Panagou P; Loukides S
Chest; 2003 Oct; 124(4):1373-80. PubMed ID: 14555568
[TBL] [Abstract][Full Text] [Related]
14. Exhaled breath condensate 8-isoprostane, clinical parameters, radiological indices and airway inflammation in COPD.
Makris D; Paraskakis E; Korakas P; Karagiannakis E; Sourvinos G; Siafakas NM; Tzanakis N
Respiration; 2008; 75(2):138-44. PubMed ID: 17641539
[TBL] [Abstract][Full Text] [Related]
15. Carbocysteine lysine salt monohydrate (SCMC-LYS) is a selective scavenger of reactive oxygen intermediates (ROIs).
Brandolini L; Allegretti M; Berdini V; Cervellera MN; Mascagni P; Rinaldi M; Melillo G; Ghezzi P; Mengozzi M; Bertini R
Eur Cytokine Netw; 2003; 14(1):20-6. PubMed ID: 12799210
[TBL] [Abstract][Full Text] [Related]
16. Dynamic hyperinflation, arterial blood oxygen, and airway oxidative stress in stable patients with COPD.
García-Rio F; Romero D; Lores V; Casitas R; Hernanz A; Galera R; Alvarez-Sala R; Torres I
Chest; 2011 Oct; 140(4):961-969. PubMed ID: 21436248
[TBL] [Abstract][Full Text] [Related]
17. Sputum eicosanoid profiling in exacerbations of chronic obstructive pulmonary disease.
Drozdovszky O; Barta I; Antus B
Respiration; 2014; 87(5):408-15. PubMed ID: 24714447
[TBL] [Abstract][Full Text] [Related]
18. [Systemic and lung inflammation in 2 phenotypes of chronic obstructive pulmonary disease].
Izquierdo JL; Almonacid C; Parra T; Pérez J
Arch Bronconeumol; 2006 Jul; 42(7):332-7. PubMed ID: 16945263
[TBL] [Abstract][Full Text] [Related]
19. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients.
Montuschi P; Corradi M; Ciabattoni G; Nightingale J; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 1999 Jul; 160(1):216-20. PubMed ID: 10390403
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Markers of Inflammation and Oxidative Stress in COPD Patients with or without Cardiovascular Comorbidities.
Kaźmierczak M; Ciebiada M; Pękala-Wojciechowska A; Pawłowski M; Nielepkowicz-Goździńska A; Antczak A
Heart Lung Circ; 2015 Aug; 24(8):817-23. PubMed ID: 25797323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
